Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.
Liz Parrish and 2yr follow-up from telomerase gene therapy
Dr. Ed Park intervewed Liz Parrish, founder of BioViva Sciences at the the 2017 RAADFest. She discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.